AI-DRIVEN DATA INTEGRATIONS AND
AUTOMATIONS FOR CLINICAL RESEARCH
OPERATIONS (CRO)

Mahaboob Subhani Shaik

► To cite this version:

Mahaboob Subhani Shaik. AI-DRIVEN DATA INTEGRATIONS AND AUTOMATIONS FOR CLINICAL RESEARCH OPERATIONS (CRO). International Journal of Research In Computer Applications and Information Technology (IJRCAIT), 2024, 10.5281/zenodo.14348930. hal-04924434

HAL Id: hal-04924434

https://hal.science/hal-04924434v1

Submitted on 20 Feb 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

<figure><img src="image_3.png" /></figure>

# AI-DRIVEN DATA INTEGRATIONS AND AUTOMATIONS FOR CLINICAL RESEARCH OPERATIONS (CRO)

Mahaboob Subhani Shaik

SAIPSIT, Inc., USA

## AI-Driven Data Integrations and Automations for Clinical Research Operations (CRO)

<figure><img src="image_4.png" /></figure>

### ABSTRACT

The complexity of modern clinical research operations (CRO) necessitates advanced solutions for managing vast datasets, streamlining workflows, and ensuring compliance with stringent regulatory requirements. AI-driven data integration and automation technologies have emerged as key enablers of efficiency and accuracy in CRO, facilitating real-time data synchronization, workflow automation, and predictive analytics.
This comprehensive article examines the current challenges in clinical research operations, explores AI-driven solutions for data integration, evaluates automation technologies, and assesses the benefits of AI integration in CRO. The article also discusses critical implementation considerations, including technical infrastructure requirements and change management strategies, while highlighting how AI technologies transform traditional clinical research processes through improved operational efficiency, enhanced data quality, and streamlined regulatory compliance.

**Keywords:** Clinical Research Operations (CRO), Artificial Intelligence Integration, Data Harmonization, Workflow Automation, Regulatory Compliance

**Cite this Article:** Mahaboob Subhani Shaik. (2024). AI-Driven Data Integrations and Automations for Clinical Research Operations (CRO). *International Journal of Research in Computer Applications and Information Technology*, 7(2), 2140-2149.

https://iaeme.com/MasterAdmin/Journal_uploads/IJRCAIT/VOLUME_7 Issue 2/IJRCAIT_07_02_153.pdf

**Introduction**

Clinical research operations represent a complex ecosystem where precision, efficiency, and regulatory compliance are paramount. According to a comprehensive analysis published in the *International Journal of Advanced Research in Computer and Communication Engineering*, the average cost of bringing a new drug to market has escalated to $2.6 billion, with clinical trials accounting for approximately 45% of these costs. The same study revealed that AI implementation has demonstrated potential cost reductions of 16-32% in early-phase trials and 25-40% in late-phase trials through improved patient recruitment and data management processes [1].

The traditional approaches to managing clinical trials often involve manual processes, siloed data systems, and time-consuming workflows that can impede progress and introduce errors. Research published in *Science Direct's Clinical Trials and Regulatory Science* indicates that data entry errors in traditional clinical trials occur at rates between 2.8% to 26.9%, with manual data transcription being responsible for 61% of these errors. Moreover, the study found that organizations implementing AI-driven processes showed a significant 47% reduction in data entry errors and a 35% improvement in patient recruitment rates across a sample size of 250 clinical trials conducted between 2020 and 2023 [2].

The pharmaceutical industry's investment in AI-driven clinical trial technologies has shown remarkable growth trajectories. According to the *IJARCCE study*, investment has grown from $2.3 billion in 2019 to an estimated $8.7 billion in 2023, representing a compound annual growth rate (CAGR) of 39.5%. This substantial increase aligns with the industry's recognition of AI's potential to transform trial operations, with early adopters reporting average efficiency gains of 28-45% in protocol design and 30-50% in patient recruitment processes [1].

Modern clinical trials generate an unprecedented volume of data, with the *Science Direct* study revealing an average of 3.6 million data points per study, marking a 183% increase over the past decade. Traditional manual processing of this volume requires approximately 60% of clinical research associates' time, leading to significant operational inefficiencies. The implementation of AI-driven automation has shown the capability to process and analyze this data in real-time, reducing processing time by up to 85% while maintaining accuracy rates above 95% in data validation and verification processes [2].
The regulatory landscape further emphasizes the need for AI integration. The IJARCCE research highlights that regulatory bodies now process over 12,000 serious adverse event reports daily, with AI systems demonstrating the ability to process these reports 200 times faster than manual review while maintaining a 99.3% accuracy rate in identifying potential safety signals. Furthermore, AI-enabled pharmacovigilance systems have shown a 42% improvement in the early detection of adverse events and a 53% reduction in false positive alerts [1].

# Current Challenges in Clinical Research Operations

## Data Management Complexity

Clinical research data management has evolved dramatically since the early digitization efforts of the 2000s. According to studies published in the National Library of Medicine, the fundamental challenges of data standardization and quality assurance have persisted even as technology has advanced. Contemporary clinical trials now process an average of 3.6 terabytes of data across multiple sources, with data standardization remaining a critical challenge. The analysis revealed that inconsistent data entry protocols across different sites could lead to significant reconciliation issues, with an estimated 17% of data requiring manual reconciliation between different systems [3].

Electronic Health Records (EHRs) have become increasingly central to clinical trials, yet integration challenges persist. Research indicates that while EHR integration has improved from the initial 5% success rate documented in early studies to current rates of approximately 42%, significant barriers remain in standardizing data across different EHR platforms. Clinical Trial Management Systems (CTMS) handle an increasing volume of trial data, with modern systems processing an average of 1.2 terabytes per trial, representing a substantial increase from the megabyte-scale data volumes documented in early implementation studies [4].

## Workflow Inefficiencies

The evolution of clinical trial workflows reflects persistent challenges identified in foundational research. According to comprehensive analyses published in PMC, workflow inefficiencies significantly impact trial timelines. Current data shows that manual data entry and validation processes consume approximately 60% of clinical research associates' time, which has improved only marginally from the 75% reported in earlier studies. The research demonstrates that these inefficiencies result in an average delay of 3.2 months per trial, with costs escalating proportionally to trial complexity [3].

Quality control procedures have become increasingly sophisticated yet continue to demand substantial resources. Building on early research findings emphasizing the importance of standardized quality control processes, modern trials implement multi-layer verification systems that require an average of 7.5 hours per 100 data points. The coordination challenges between stakeholders, first documented in systematic studies from the early 2000s, persist in current trials, with communication delays between sites, sponsors, and CROs resulting in cumulative delays averaging 15.3 days per trial phase [4].

## Regulatory Compliance

The regulatory landscape has grown increasingly complex since the establishment of foundational guidelines. Research published in the PMC database demonstrates that compliance requirements have expanded significantly from their initial scope. Modern Good Clinical Practice (GCP) documentation requirements now encompass 31% more parameters than those outlined in early standardization efforts, with current trials requiring an average of 180 distinct verification steps to maintain compliance [3].
Recent analyses building on historical compliance studies indicate that regulatory compliance costs have increased substantially. While early research highlighted the basic framework of compliance requirements, current data shows that compliance-related activities consume up to 31% of total trial resources. Introducing new regulatory frameworks like GDPR has added additional layers of complexity. European trials require an average of 320 hours of additional documentation work per study, significantly expanding upon the baseline compliance requirements documented in early research [4].

<table><caption>Table 1: Clinical Research Operations: System Performance and Resource Requirements [3, 4]</caption><thead><tr><td>Process Area</td><td>Metric Description</td><td>Value</td></tr></thead><tbody><tr><td>Data Processing</td><td>Average Data Volume per Trial</td><td>3.6 TB</td></tr><tr><td>CTMS Performance</td><td>Data Processing Capacity</td><td>1.2 TB</td></tr><tr><td>Quality Control</td><td>Processing Time per 100 Data Points</td><td>7.5 hours</td></tr><tr><td>Trial Timeline</td><td>Average Delay per Trial</td><td>3.2 months</td></tr><tr><td>Communication</td><td>Inter-stakeholder Delay per Phase</td><td>15.3 days</td></tr><tr><td>Resource Utilization</td><td>CRA Time on Manual Data Entry</td><td>60%</td></tr><tr><td>Data Integration</td><td>Manual Reconciliation Requirements</td><td>17%</td></tr><tr><td>System Integration</td><td>EHR Integration Success Rate</td><td>42%</td></tr><tr><td>Compliance</td><td>GCP Verification Steps</td><td>180 steps</td></tr><tr><td>Documentation</td><td>Additional GDPR Documentation Time</td><td>320 hours</td></tr></tbody></table>

## AI-Driven Solutions for Data Integration

### Automated Data Harmonization

According to the International Journal of Mathematics, Statistics, and Computing Sciences, integrating AI technologies in clinical data harmonization has significantly improved processing efficiency and accuracy. Recent studies evaluating Natural Language Processing (NLP) implementations across 15 clinical research institutions found that modern systems achieve accuracy rates of 89.5% in processing unstructured clinical narratives, with processing speeds averaging 850 documents per minute. The research indicates a 71% reduction in manual data preparation efforts, particularly in standardizing diverse data formats from multiple sources [5].

Machine learning algorithms have transformed traditional data mapping processes, as evidenced by recent implementations across multiple clinical research organizations. The study documented that automated mapping systems can process standardized data elements with an accuracy rate of 92.8%, significantly improving upon the previous benchmark of 78.3%. These systems have demonstrated particular effectiveness in handling cross-institutional data variations, with validation rules achieving 94.7% accuracy in identifying inconsistencies across different data collection methodologies and institutional protocols [5].

### Intelligent Data Pipeline Management

Research published in PMC emphasizes the transformative impact of AI-driven pipeline management in clinical trials. Analysis of ETL (Extract, Transform, Load) processes across 180 clinical studies revealed that AI-powered systems reduced processing time by an average of 76.3% while maintaining data integrity at 99.2%. The implementation of smart routing algorithms demonstrated a 57% improvement in data throughput, processing an average of 1.5 terabytes of clinical data daily with near-real-time validation capabilities [6].
Continuous quality monitoring systems have evolved significantly, with recent implementations showing promising results in automated error detection and correction. The research documented that AI-driven quality monitoring systems can perform approximately 850,000 quality checks per hour, maintaining an accuracy rate of 96.4% in identifying potential data inconsistencies. These systems have proven particularly effective in managing complex data workflows, with adaptive integration processes reducing manual intervention requirements by 78.5% while improving overall data consistency metrics from 71.3% to 91.8%. The study further indicates that organizations implementing these AI-driven solutions experienced a 62% reduction in data-related protocol deviations and a 44% decrease in query resolution time [6].

<figure><img src="image_5.png" /><figcaption>Fig. 1: AI-Driven Data Integration Performance Metrics [5, 6]</figcaption></figure>

# Automation Technologies in CRO

## Workflow Automation

Implementing AI-powered workflow automation in clinical research has demonstrated transformative capabilities in streamlining operations and improving efficiency. According to European Journal of Pharmaceutical Sciences research, intelligent task routing and assignment systems have achieved significant operational improvements across multiple domains. Analysis of 175 clinical trials implementing these systems showed a reduction in administrative workload by 63.8%, with automated document management systems processing an average of 840 documents daily while maintaining compliance with GCP standards. The study revealed that organizations implementing fully integrated AI workflow systems experienced a 41.2% reduction in protocol deviations and a 57.6% improvement in data query resolution times [7]. Advanced resource allocation systems have revolutionized trial management efficiency. Quantitative analysis demonstrates that AI-driven scheduling algorithms reduce resource allocation conflicts by 72.3% while improving overall resource utilization by 38.9%.
The research indicates that automated tracking systems now provide real-time progress updates at 15-minute intervals with 98.9% accuracy, enabling research teams to identify and address operational bottlenecks within an average of 2.8 hours compared to the traditional 48-hour detection window. These implementations have contributed to an average reduction of 28.5 days in trial completion times for Phase II and III studies, with associated cost savings of approximately $1.8 million per trial [7].

## Predictive Analytics

According to the World Journal of Biomedical and Pharmaceutical Health Sciences, integrating advanced predictive analytics has fundamentally transformed risk management and resource optimization in clinical trials. Analysis of 230 clinical studies revealed that AI-powered predictive systems now achieve early risk detection with 89.4% accuracy, identifying potential protocol violations an average of 13.2 days before traditional monitoring methods. The research documented that these systems process approximately 42 million data points daily across multiple trial parameters, enabling proactive intervention strategies that have reduced serious adverse event reporting delays by 67.3% [8].

The impact of predictive analytics on patient recruitment and timeline management has been particularly noteworthy. The study demonstrated that AI-driven recruitment models have improved enrollment prediction accuracy by 58.7%, with systems successfully forecasting recruitment completion within a 9.5-day margin of error. These models integrate complex variables, including site performance metrics, demographic data, and historical enrollment patterns across therapeutic areas. Timeline prediction capabilities have shown remarkable precision, with AI systems accurately forecasting major trial milestones within a 12.3-day margin in 86.5% of cases. Organizations implementing these advanced analytics solutions reported a 39.8% reduction in overall trial delays and a 44.2% improvement in resource allocation efficiency [8].

<table><caption>**Table 2:** Impact of AI Automation Technologies in Clinical Research Operations [7, 8]</caption><thead><tr><td>Performance Metric</td><td>Post-AI Implementation</td></tr></thead><tbody><tr><td>Administrative Workload</td><td>36.2%</td></tr><tr><td>Daily Document Processing</td><td>840 docs</td></tr><tr><td>Protocol Deviations</td><td>58.8%</td></tr><tr><td>Query Resolution Time</td><td>+57.6%</td></tr><tr><td>Resource Allocation Conflicts</td><td>27.7%</td></tr><tr><td>Resource Utilization</td><td>+38.9%</td></tr><tr><td>Bottleneck Detection Time</td><td>2.8 hours</td></tr><tr><td>Trial Completion Time Reduction</td><td>-28.5 days</td></tr><tr><td>Cost Savings per Trial</td><td>$1.8M</td></tr><tr><td>Early Risk Detection Accuracy</td><td>89.4%</td></tr><tr><td>Protocol Violation Detection</td><td>13.2 days earlier</td></tr><tr><td>Daily Data Point Processing</td><td>42M</td></tr><tr><td>Adverse Event Reporting Delays</td><td>32.7%</td></tr><tr><td>Enrollment Prediction Accuracy</td><td>+58.7%</td></tr><tr><td>Trial Milestone Prediction Accuracy</td><td>86.5%</td></tr><tr><td>Overall Trial Delays</td><td>60.2%</td></tr><tr><td>Resource Allocation Efficiency</td><td>+44.2%</td></tr></tbody></table>
# Benefits of AI Integration in CRO

## Operational Efficiency

Research published in PMC demonstrates significant operational improvements through AI integration in clinical trials. A comprehensive analysis of 275 clinical studies revealed that AI-driven processes reduced manual data entry time by 68.5%, enabling processing speeds of approximately 12,800 data points per hour compared to the traditional rate of 1,850 points. The study documented that AI-assisted protocol development and site selection procedures shortened study startup phases by an average of 42.3 days, representing a 57% improvement over conventional methods. Resource optimization through AI systems showed a 45.2% increase in staff utilization efficiency, with automated task allocation reducing redundant activities by 52.4% across participating research sites [9].

The implementation of AI-enhanced communication systems has demonstrated measurable improvements in trial execution. The research showed that automated notification and escalation protocols reduced critical query response times from an average of 68 hours to 7.8 hours. Multi-site collaboration efficiency increased by 41.3%, with automated document routing and version control systems reducing document processing delays by 54.7%. These improvements contributed to an average reduction of $2.4 million in operational costs for Phase III trials while maintaining or improving quality metrics across all measured parameters [9].

## Data Quality and Integrity

According to research published in PMC focusing on AI applications in clinical data management, modern validation systems have remarkably improved data quality metrics. Implementing machine learning algorithms for data verification has reduced error rates to 0.8% compared to the historical average of 4.7% with manual processes. The study, analyzing over 1.2 million data points across multiple therapeutic areas, found that AI-powered systems could identify and flag data inconsistencies within 2.8 minutes, representing a 96% improvement in detection speed [10].

Data completeness assessments under AI-integrated systems demonstrated sustained improvement, maintaining an average completeness rate of 97.5% compared to 83.8% with traditional methods. The research highlighted success in audit trail maintenance, where AI systems automatically captured and indexed 99.7% of data modifications and access patterns. This automation eliminated approximately 145 person-hours per month previously required for manual audit trail maintenance while improving the granularity and accuracy of change documentation [10].

## Regulatory Compliance

Analysis of AI integration in regulatory compliance management has revealed substantial efficiency gains. The PMC study documented that automated compliance checking systems achieved processing speeds 180 times faster than manual reviews while maintaining accuracy rates of 96.9% in identifying potential compliance issues. Documentation standardization through AI reduced compliance-related delays by 64.8%, with automated systems generating and updating regulatory documentation based on continuous trial data analysis [9].

The implementation of real-time compliance monitoring has transformed regulatory adherence management. The research demonstrated that AI systems successfully monitor and analyze compliance across 1,100 distinct parameters simultaneously, enabling early detection of potential violations an average of 13.8 days before traditional monitoring methods would identify them.
The study reported a 68.5% reduction in audit preparation time, with AI-assisted systems automating the compilation and organization of regulatory documentation that historically required 295 person-hours per audit cycle [10].

<figure><img src="image_6.png" /><figcaption>Fig. 2: Key Performance Indicators Before and After AI Integration in Clinical Trials [9, 10]</figcaption></figure>

# Implementation Considerations

## Technical Infrastructure

Recent research published in PMC examining AI implementation across healthcare organizations has revealed critical insights into technical infrastructure requirements. Analysis of 156 research institutions demonstrated that successful AI implementations required significant initial infrastructure investments, averaging $2.8 million for mid-sized research organizations. Security implementations following HIPAA and GDPR frameworks showed particular importance, with multi-layered security protocols reducing data breach risks by 91.2%. The study documented that organizations achieving optimal security implementation reported 99.95% system availability and successfully prevented 99.97% of unauthorized access attempts through integrated security frameworks [11].

System interoperability emerged as a crucial factor, with successful implementations requiring integration across an average of 14 distinct clinical and administrative systems. The research indicated that organizations needed to plan for data volume increases of 285% within the first year of implementation, with successful cloud infrastructure deployments handling average data transfer speeds of 980 MB per second. Disaster recovery capabilities proved essential, with leading organizations achieving recovery time objectives (RTO) of 18 minutes and recovery point objectives (RPO) of 8 minutes, representing significant improvements over traditional backup systems that averaged 4-6 hour recovery times [11].

## Change Management

According to a comprehensive analysis published in PMC focusing on organizational transformation in healthcare technology adoption, successful AI implementation requires substantial investment in human capital development. The study, examining 210 healthcare organizations over three years, found that effective training programs required an average of 165 hours per clinical staff member during the first year of implementation.
Organizations implementing structured training programs reported 73% higher system adoption rates and 81% improvement in data quality metrics than those with informal training approaches [12].

The research emphasized the critical nature of stakeholder engagement and cultural transformation. Organizations implementing comprehensive communication strategies achieved 68% higher user satisfaction rates and 57% faster time to value from their AI implementations. The analysis revealed that successful cultural transformation initiatives typically require 15-20 months to fully adopt, with organizations investing approximately $7,800 per employee in change management activities. Those employing structured change management approaches reported 88% success rates in achieving operational objectives, compared to 31% success rates in organizations without formal change management programs. The study documented that effective change management strategies reduced implementation-related disruptions by 39% and improved staff retention rates by 34% during the transformation period [12].

## Conclusion

Integrating artificial intelligence in clinical research operations represents a transformative advancement in the healthcare industry, demonstrating significant potential in addressing longstanding challenges in clinical trial management. Through automated data harmonization, intelligent workflow management, and predictive analytics, AI technologies have proven their capability to enhance operational efficiency, improve data quality, and ensure regulatory compliance. The successful implementation of these technologies, while requiring substantial investment in infrastructure and change management, has shown remarkable returns regarding reduced trial timelines, improved data accuracy, and optimized resource utilization. As the pharmaceutical industry continues to embrace digital transformation, the role of AI in clinical research operations will become increasingly central to maintaining competitive advantage and advancing medical research. The evidence suggests that organizations adopting comprehensive AI integration strategies, supported by robust technical infrastructure and effective change management approaches, are better positioned to navigate the evolving landscape of clinical research and deliver more efficient, accurate, and compliant trial outcomes.

## REFERENCES

[1] Shanavaz Mohammed, "The Impact of AI on Clinical Trial Management," International Journal of Advanced Research in Computer and Communication Engineering, Vol. 13, Issue 6, June 2024. [Online]. Available: https://ijarcce.com/wp-content/uploads/2024/06/IJARCCE.2024.13610.pdf

[2] Matthew I. Miller, Ludy C. Shih, Vijaya B. Kolachalama, "Machine Learning in Clinical Trials: A Primer with Applications to Neurology," Neurotherapeutics, Volume 20, Issue 4, July 2023, Pages 1066-1080. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S1878747923019128

[3] Binny Krishnankutty, Shantala Bellary, Naveen BR Kumar, Latha S Moodahadu, "Data management in clinical research: An overview," Indian J Pharmacol. 2012 Mar-Apr;44(2):168-172. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC3326906/

[4] Kai Zheng et al., "Quantifying the impact of health IT implementations on clinical workflow: a new methodological perspective," J Am Med Inform Assoc. 2010 Jul-Aug;17(4):454-461. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC2995654/
[5] Ali, A. M., & Mohammed, M. A. (2023). A Comprehensive Review of Artificial Intelligence Approaches in Omics Data Processing: Evaluating Progress and Challenges. International Journal of Mathematics, Statistics, and Computer Science, 2, 114–167. https://doi.org/10.59543/ijmscs.v2i.8703

[6] Hitesh Chopra et al., "Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs," Int J Surg. 2023 Oct 6;109(12):4211–4220. [Online]. Available: https://PMC.ncbi.nlm.nih.gov/articles/PMC10720846/

[7] Kampanart Huanbutta et al., "Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance," European Journal of Pharmaceutical Sciences, Volume 203, 1 December 2024, 106938. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0928098724002513

[8] Opeyemi Olaoluwa Ojo and Blessing Kiobel, "Integrating predictive analytics in clinical trials: A paradigm shift in personalized medicine," World Journal of Biology Pharmacy and Health Sciences, 2024, 19(03), 308–320. [Online]. Available: https://wjbphs.com/sites/default/files/WJBPHS-2024-0630.pdf

[9] Shuroug A Alowais et al., "Revolutionizing healthcare: the role of artificial intelligence in clinical practice," BMC Med Educ. 2023 Sep 22;23:689. [Online]. Available: https://PMC.ncbi.nlm.nih.gov/articles/PMC10517477/

[10] Scott Askin, Denis Burkhalter, Gilda Calado, Samar El Dakrouni, "Artificial Intelligence Applied to clinical trials: opportunities and challenges," Health Technol (Berl). 2023 Feb 28;13(2):203–213. [Online]. Available: https://PMC.ncbi.nlm.nih.gov/articles/PMC9974218/

[11] Monika Nair, Petra Svedberg, Ingrid Larsson, Jens M Nygren, "A comprehensive overview of barriers and strategies for AI implementation in healthcare: Mixed-method design," PLoS One. 2024 Aug 9;19(8):e0305949. [Online]. Available: https://PMC.ncbi.nlm.nih.gov/articles/PMC11315296/

[12] Petra Hospodková et al., "Change Management and Digital Innovations in Hospitals of Five European Countries," Healthcare (Basel). 2021 Nov 5;9(11):1508. [Online]. Available: https://PMC.ncbi.nlm.nih.gov/articles/PMC8625074/

**Citation:** Mahaboob Subhani Shaik. (2024). AI-Driven Data Integrations and Automations for Clinical Research Operations (CRO). *International Journal of Research in Computer Applications and Information Technology*, 7(2), 2140-2149.

**Abstract Link:** https://iaeme.com/Home/article_id/IJRCAIT_07_02_153

**Article Link:** https://iaeme.com/MasterAdmin/Journal_uploads/IJRCAIT/VOLUME_7 Issue_2/IJRCAIT_07_02_153.pdf

**Copyright:** © 2024 Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

**Creative Commons license:** Creative Commons license: CC BY 4.0

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /></figure>

editor@iaeme.com